Pathologically relevant trypsinogen activation in pancreatitis
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.02.2026 · 330 (2) · G87-G97
DOI: 10.1152/ajpgi.00152.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.02.2026. Verfasst von Andrea Geisz-Fremy. Beteiligte Einrichtung: Department of SurgeryBoston University Chobanian & Avedisian School of Medicine Boston Massachusetts United States. Hauptthemen laut MEDLINE: Trypsinogen, Pancreatitis, Trypsin, Pancreas. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Pancreatitis is an inflammatory disorder of the pancreas that occurs in acute, recurrent acute, and chronic forms, often leading to severe complications and long-term functional impairment. The disease develops through multiple pathological mechanisms, including the premature activation of the digestive proenzyme trypsinogen within the pancreas. Conversion of trypsinogen to its active form trypsin may be catalyzed by the lysosomal protease cathepsin B or may occur through autoactivation, a self-amplifying reaction in which trypsin activates trypsinogen. Accumulating evidence from genetic, biochemical, and animal model studies on trypsinogen mutations associated with human pancreatitis strongly supports autoactivation as a key driver of disease pathogenesis, whereas cathepsin B-mediated activation may play a context-dependent, lesser role. This review explores the biochemical pathways of intrapancreatic trypsinogen activation and discusses their respective contributions to the multifactorial pathogenesis of pancreatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of SurgeryBoston University Chobanian & Avedisian School of Medicine Boston Massachusetts United States.
ORCID-Profile: Andrea Geisz-Fremy
Förderung
- NIDDK NIH HHS
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Geisz-Fremy, A. (2026). Pathologically relevant trypsinogen activation in pancreatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 330(2), G87-G97. https://doi.org/10.1152/ajpgi.00152.2025
Vancouver
Geisz-Fremy A. Pathologically relevant trypsinogen activation in pancreatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2026;330(2):G87-G97. doi:10.1152/ajpgi.00152.2025
BibTeX
@article{GeiszFremy2026,
author = {Geisz-Fremy, Andrea},
title = {Pathologically relevant trypsinogen activation in pancreatitis},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2026},
volume = {330},
number = {2},
pages = {G87--G97},
doi = {10.1152/ajpgi.00152.2025}
}
EUVIMED